[This review was originally posted at the Nieman Journalism Lab Glucophage For Sale, on Dec. 9, 2011.]

Do institutions have a place in news innovation?: About three weeks after Dean Starkman's indictment of future-of-news thinkers was posted online by the Columbia Journalism Review, NYU professor Clay Shirky — one of the primary targets of the piece — delivered a response late last week in the form of a thoughtful essay on the nature of institutions and the news industry. Shirky explained the process by which institutions can lapse into rigidity and blindness to their threats, and he argued that there's no way to preserve newspapers' most important institutional qualities in the digital age, buy Glucophage from mexico, so the only option left is radical innovation.

Several observers — of a future-of-news orientation themselves — jumped in to echo Shirky's point. The Journal Register Co.'s Steve Buttry praised Shirky for waiting and reflecting rather than responding immediately, and media consultant Steve Yelvington seconded Shirky's point that all this talk about traditional journalistic models being overwhelmed by a decentralized, Effects of Glucophage, audience-focused digital tidal wave is descriptive, not prescriptive — not necessarily the way things should be, but simply the way they are.

Howard Owens of the Batavian took the middle ground, declaring that evolution, not revolution, is the standard vehicle for change in journalism and laying a model for sustainable local journalism that focuses on local ownership, startups, and innovation, Glucophage For Sale. In the end, Owens wrote, online journalism will evolve and survive. "It will find ways to make more and more money to pay for more and more journalism.  The audience is there for it, Glucophage wiki, local businesses will always want to connect with that audience, and entrepreneurial minded people will find ways to put the pieces together."

The Atlantic's Alexis Madrigal raised a good point in the discussion about how to preserve serious journalism: He argued that the primary obstacle won't be so much about paying for journalists to cover important public-affairs issues, but about finding a way for that news to reach a substantial percentage of the population in a given area. That "amplification" problem may be tough to solve, Fast shipping Glucophage, but could be relatively easy to scale once that initial solution is found.

—

Paywalls picking up steam among smaller papers: Now that the New York Times has bravely served as a paywall guinea pig for the rest of America's newspapers (apparently successfully, judging from the indicators we have so far), we're starting to see more of the nation's mid-sized papers announce online pay plans of their own. This week, Gannett, Glucophage used for, the U.S.' largest newspaper chain, revealed that it would be expanding its paywalls to more of its papers sometime next year. According to the Gannett Blog Glucophage For Sale, , the company began experimenting with paywalls at three newspapers last year, and while we don't know much of anything about those projects, it appears Gannett is pleased enough with them to build out on that model.

The Chicago Sun-Times also announced a paywall to begin this week: It'll follow the increasingly popular metered model employed by the Financial Times and New York Times, allowing 20 page views per 30-day period before asking for $6.99 a month ($1.99 for print subscribers). Buy generic Glucophage, PaidContent noted that the plan is being run by Press+ (the system created by Steve Brill's former Journalism Online) and that Roger Ebert has been exempted from the paywall.

We also got a couple of updates from existing newspaper paywalls: MinnPost reported that the Minneapolis Star Tribune has come out ahead so far in its new paywall, generating an estimated $800,000 in subscriptions while losing a five-figure total of advertising dollars. And PaidContent reported that three paywalled MediaNews Group papers (now run by John Paton of the Journal Register Co.) have killed their Monday print editions, with a corresponding drop of their online paywall on those days, Glucophage samples.

—

Is this blogger a journalist?: Just when you thought the "Are bloggers journalists?" discussion was completely played out, it got some new life this week when an Oregon judge ruled that a blogger being sued for $2.5 million in a defamation case wasn't protected by the state's media shield law because she wasn't a journalist, Glucophage For Sale. As Seattle Weekly initially reported, the judge reasoned that she wasn't a journalist because she wasn't affiliated with any "newspaper, magazine, periodical, What is Glucophage, book, pamphlet, news service, wire service, news or feature syndicate, broadcast station or network, online Glucophage without a prescription, or cable television system."

This type of ruling typically gets bloggers (and a lot of journalists) riled up, and rightly so. Mathew Ingram of GigaOM gave some great context regarding state-by-state shield laws, noting that several other recent rulings have defined who's a journalist much more broadly than this judge did. Online buying Glucophage, These types of distinctions based on institutional affiliation are attempts to hold back a steadily rising tide, he argued.

On the other hand, Forbes' Kashmir Hill described some of the case's background that seemed to indicate that this particular blogger was much more intent on defamation than performing journalism, creating dozens of sites to dominate the search results for the company she was attacking, then emailing the company to offer $2, Glucophage australia, uk, us, usa,500/mo. Glucophage For Sale, online reputation management. Hill concluded, "Yes, bloggers are journalists. Glucophage dosage, But just because you have a blog doesn’t mean that what you do is journalism." Libertarian writer Julian Sanchez agreed, saying that while the judge's ruling wasn't well worded, this blogger was not a journalist.

—

Facebook's new tools: A few Facebook-related notes: The social network began rolling out Timeline, the graphical life-illustration feature it announced back in September this week, starting in New Zealand, Glucophage cost. It also briefly, vaguely announced plans to extend its Twitter-like Subscribe button into a plugin for websites, a move that TechCrunch said signifies that "the company is directly attacking the entire Twitter model head-on." Cory Bergman of Lost Remote urged news orgs to get on the Subscribe bandwagon as soon as they can, as a way to extend their journalists' brands.

Meanwhile, news business consultant Alan Mutter laid out a basic plan for publishers to not just gain audience on Facebook, but make money there, too, Glucophage For Sale. Glucophage pics, The key element of that plan may be a surprising one: "The most intriguing and perhaps most productive approach for making money off Facebook, however, is for newspapers to take over the social media marketing and advertising campaigns for businesses in their markets."

—

Reading roundup: Pretty slow week this week, but there were a few smaller stories worth keeping an eye on:

— As a sort of sequel to the Huffington Post's OffTheBus effort in the 2008 U.S. presidential campaign, Jay Rosen and NYU's Studio 20 are partnering with the Guardian to determine and cover "the citizens' agenda" in the 2012 election, Glucophage brand name. Rosen and NYU will also be working with MediaNews and the Journal Register Co. on the local and regional level. Glucophage For Sale, At the Lab, Megan Garber explained what's behind the initiative.

— The American Journalism Review published a piece on the journalistic ethics of retweeting that included news that the Oregonian is telling its reporters to consider all retweets as endorsements. The Journal Register Co.'s Steve Buttry rounded up (appalled) reaction and argued that editors should consider each case individually.

— Ten NBC-owned TV stations in Chicago, Philadelphia, and Los Angeles will work with nonprofit news orgs (public radio in LA and Philly, and the Chicago Reporter and ProPublica) in a new initiative first reported by the LA Times.

— The popular iPad news aggregation app Flipboard launched for iPhone this week, and Poynter's Jeff Sonderman drew lessons on mobile design for news orgs from it.

— The New York Times reported that most of the pack of would-be iPad competitors in the tablet market have fizzled out, though the Kindle Fire and Nook Tablet have gotten off to promising starts.

— Here at the Lab, longtime newspaper editor Tom Stites is in the midst of an interesting three-part series on the state of web journalism. Part one is a good overview of where we are and where we want to go, and part two looks at the wide-ranging effects of layoffs and cuts into local journalism.

Similar posts: Diflucan Over The Counter. Retin A Dosage. Purchase Zoloft. Discount Cephalexin. Canada, mexico, india. Zoloft used for.
Trackbacks from: Glucophage For Sale. Glucophage For Sale. Glucophage For Sale. Where can i buy cheapest Glucophage online. Buy Glucophage without a prescription. Buy generic Glucophage.

Order Lipitor, [This review was originally posted on Sept. 23, 2011, at the Nieman Journalism Lab.]

Facebook ramps its sharing up even further: We had been hearing all week about a big announcement Facebook would be making this Thursday at its annual conference — about how it would mark the social network's rebirth and leave the competition in the dust. So here's what we got (in a handy roundup from Gizmodo): A Twitter-like mini-feed called Ticker (meant to make the News Feed look more like "your own personal newspaper"), apps on Facebook's Open Graph, sharing music and games through integration with services like the music player Spotify, No prescription Lipitor online, and Timeline, essentially a one-page Facebook life story.

It's pretty clear what Facebook's goal is with all of this: Put charitably, as Wired's Mike Isaac did, it's "allowing for the Facebook page to be a sort of one-stop shop, scooping up all of your activities and displaying them in one grand, blue and white frame." Put more skeptically, as the New Yorker's Nicholas Thompson did, is Lipitor addictive, Facebook wants to eat up a large chunk of the Internet, which has some real consequences: "The more our online lives take place on Facebook, the more we depend on the choices of the people who run the company—what they think about privacy, how they think we should be able to organize our friends, what they tell advertisers (and governments) about what we do and what we buy."

Tom Foremski of Silicon Valley Watcher made the point a different way, arguing that Facebook is trying to combat the natural slowdown in how much we're willing to share online by making it more frictionless and ubiquitous. Lipitor alternatives, Reactions were similar in displaying two sides of the same coin: The ability to pull together a lot of old social information into a single Timeline was either "something a lot of users wanted without much of a voice asking for it" (ZDNet's Rachel King) or a fix to "a problem absolutely no one was clamoring about" (Gawker's Adrian Chen). We'll get more of a sense of which side is more accurate over the next several months, Order Lipitor.

—

Facebook meets news apps: Another one of the changes announced by Facebook on Thursday was the addition of several new Facebook-based news apps, the first of which was the Wall Street Journal's WSJ Social, unveiled on Tuesday. (Others, like the Washington Post's and Yahoo's, were announced on Thursday.) As the Lab's Megan Garber explained, the app allows each user to edit their own stream of Journal material, is Lipitor safe, and to follow and rank others based on their editing.

As Forbes' Jeff Bercovici pointed out, the app seems to serve both the Journal's and Facebook's interests quite nicely: It keeps people's news consumption and interaction within Facebook, but allows the Journal to sell its own ads within the app and keep the money. (Facebook gets everything for the ads outside the app.)

There were questions about the app — Adweek's Dylan Byers wondered how fond people would be of an app that curates content from only one source, and GigaOM's Mathew Ingram questioned how well the socially oriented app would work with a hard paywall, Herbal Lipitor, and more generally, whether it's wise for news organizations to leave so much of their user interaction inside Facebook.

—

AOL's struggles and the future of online content: The AOL/TechCrunch saga Order Lipitor, seems to be (mercifully) winding down this week — the last real drama took place late last week, when one TechCrunch writer, Paul Carr, quit with a scorched-earth post directed at new editor Erick Schonfeld, and Schonfeld disputed his claims. But the bad news continues to roll in for AOL: The sales director for its hyperlocal news project, Patch, left — the second top AOL ad exec to bolt in the past month. Business Insider reported that AOL may lose $30 million on Patch this year. And AOL's prospects as a content-based company in general don't look rosy, as paidContent's Robert Andrews pointed out, online Lipitor without a prescription, looking at the declining revenues for AOL Europe once it dropped Internet access from its business model.

AOL execs remain positive in the face of all the bad news: Arianna Huffington said her Huffington Post's merger with AOL has been a boon for both HuffPo and Patch, thanks to the new synergies between the two operations. On the advertising side, AOL CEO Tim Armstrong said he hopes to catch Microsoft and Google in online display ads, a tall task, Order Lipitor.

Outside the company, of course, skeptics still abound. Where can i find Lipitor online, Bloomberg Businessweek's Peter Burrows declared AOL and its fellow web portal Yahoo dead companies walking, saying they "have tried to live by Old Media rules while masquerading as New Media powerhouses." And at Adweek, Michael Wolff pointed to AOL and Yahoo's struggles as evidence that online content can't sustain a business model. The only content that can still do that, he said, is TV or video: "What still works, what advertisers and audiences still seek, is superexpensive content."

—

Netflix's big split: It wasn't related to journalism per se, Lipitor pictures, but the big story at the intersection of media and tech this week was the announcement of Netflix's split into two businesses — one for streaming video online, and a new one, Qwikster, to continue its DVD-by-mail service. The change was welcomed by approximately no one: Not users or investors, as the New York Times reported, Buy generic Lipitor, not analysts like Business Insider's Henry Blodget (who said it's bad for customers) and paidContent's Robert Andrews (who said it's bad for business), and not the Oatmeal's Matthew Inman, who summed up the head-scratching nature of the move as well as anyone. Order Lipitor, Of course, Netflix had to have a reason for doing this, and there were several popular guesses, rounded up well by Tim Carmody of Wired. As Carmody explained, there are two main theories: 1) Separating DVDs and streaming makes it easier and cheaper for Netflix to negotiate rights with Hollywood (best articulated by venture capitalist Bill Gurley), and 2) Netflix wants to let its DVD business die in peace, without taking streaming down with it (argued in two posts by tech writer Dan Frommer). Along the lines of the latter theory, rx free Lipitor, GigaOM's Mathew Ingram likened Netflix's situation to the news business and wondered who would be the first newspaper company to spin off its print product from its digital side.

—

The News Corp. scandal and a press freedom threat: It's been a couple of months since News Corp.'s phone-hacking scandal was making big headlines, but the problems stemming from it continue to spread week by week. Deadline New York's David Lieberman looked at some of the financial signs indicating that the fallout may not be isolated to News Corp.'s British newspaper division, Order Lipitor. This week, a couple of aspects of the scandal heated up as another wound down: News Corp. Lipitor over the counter, is expected to settle its highest-profile hacking case (with the family of a murdered 12-year-old girl) for $4.7 million, while the U.S. Justice Department reportedly began asking the company for information in its investigation into bribery charges, and new allegations of hacking into a former government official's voicemail emerged.

Meanwhile, apart from News Corp., the story briefly sparked a press freedom fight when Scotland Yard invoked an espionage law to threaten the Guardian to give up its anonymous sources on one of the hacking cases. Order Lipitor, Journalists across Britain, including some from competitors like the Daily Mail, rose up to defend the Guardian, and within a few days, police dropped their threat. The backlash was strong enough that members of Parliament will question one of Scotland Yard's top officials over the plan, about Lipitor.

—

Reading roundup: Tons of other little things going on this week. Here's a quick tour:

— Some interesting media fallout from WikiLeaks' recent diplomatic cable release: Al Jazeera's news director resigned after the cables showed that he had modified the network's Iraq war coverage based on pressure from the U.S. This, of course, raised questions about Al Jazeera's independence and credibility. Elsewhere, British journalism thinker Charlie Beckett talked about what WikiLeaks can tell us about where news is headed, Order Lipitor. Buy Lipitor without a prescription, — Though its changes were trumped by Facebook, Google+ unveiled several new features and announced that it's open to everyone. J-prof Dan Reimold declared the new social network dead, but Wired's Tim Carmody explained how Google+'s changes are meant to change that.

— The Washington Post's Monica Hesse wrote a thought-provoking piece on journalists' tendency to obsess with things happening on social networks, leading to insights that ... aren't that insightful. If you're interested in using social media in a way that's actually worthwhile, fast shipping Lipitor, Poynter's Mallary Jean Tenore has a good guide to ways journalists can use Twitter before, during, and after reporting a story.

— At Silicon Valley Watcher, Matthew Buckland did a fascinating Q&A with Wired editor Chris Anderson — the first half on the decline of the open web, and the second on what journalism is now. Lipitor steet value, — This week's most interesting piece of media-related research comes from NYU's Tim Libert, who looked at thousands of comments about the online hacking group LulzSec, finding that the discourse indicated that the group is "in the position of villain rather than the champion of the people’s rights, as they would presumably like to be seen."

— Finally, the AP's Jonathan Stray wrote a stirring piece on what it would look like if we merged journalism with "maker culture," concluding, "This is a theory of civic participation based on empowering the people who like to get their hands dirty tinkering with the future. Maybe that’s every bit as important as informing voters or getting politicians fired.".

Similar posts: Zoloft For Sale. Purchase Cephalexin. Order Glucophage. Low dose Zoloft. Lipitor duration. Zoloft pictures.
Trackbacks from: Order Lipitor. Order Lipitor. Order Lipitor. Generic Lipitor. Taking Lipitor. Where to buy Lipitor.